DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Suven Life Sciences Limited — Monitoring Agency Report

NSE 3 hrs ago·11 Aug 2026, 7:07 am

Suven Life Sciences

Suven Life Sciences has released a monitoring agency report for the quarter ended June 30, 2026. This report is a standard regulatory filing that provides an independent assessment of the company's financial health and operational status during the specified period.

For investors, this disclosure is important as it offers an external verification of the company's reported figures. It helps validate the accuracy of the financial statements and ensures transparency in reporting, which is a key factor for maintaining investor confidence.

Investors should watch for any specific observations or comments made by the monitoring agency regarding the company's performance or compliance. This information can provide additional context to the financial data and help in assessing the company's current standing.